Frozen Shoulder (Adhesive Capsulitis)

1. Clinical Overview

Summary

Frozen Shoulder (Adhesive Capsulitis) is a condition characterised by progressive loss of both active AND passive range of motion (ROM) of the glenohumeral joint, resulting from idiopathic fibrosis and contracture of the joint capsule. The condition affects 2-5% of the general population, with peak incidence in individuals aged 40-60 years and a slight female predominance (female:male ratio 1.4:1). [1,2]

The hallmark pathological feature is capsular contracture with loss of the axillary recess, leading to global restriction of shoulder movement following a characteristic capsular pattern (External Rotation > Abduction > Internal Rotation). The key diagnostic feature is equal restriction of active and passive ROM, distinguishing it from rotator cuff pathology where passive movement is typically preserved. [3]

Frozen shoulder exhibits a strong association with diabetes mellitus: 10-20% of diabetic patients develop the condition (compared to 2-5% in the general population), representing a 5-fold increased risk. Diabetic patients experience more severe symptoms, longer disease duration, increased bilateral involvement, and poorer response to treatment. [4,5]

The natural history follows three distinct clinical phases over 18-24 months: [6]

1. Freezing (Painful) Phase (2-9 months): Inflammatory synovitis, progressive pain (particularly night pain disrupting sleep), increasing stiffness
2. Frozen (Stiff) Phase (4-12 months): Dominant fibrotic proliferation, pain decreases, maximal stiffness with global ROM restriction
3. Thawing (Recovery) Phase (12-24 months): Capsular remodeling, gradual improvement in ROM, residual stiffness in 10-20%

Management is primarily conservative with physiotherapy, NSAIDs, and intra-articular corticosteroid injection (most effective in the freezing phase). Refractory cases may benefit from hydrodilatation (arthrographic distension), manipulation under anaesthesia (MUA), or arthroscopic capsular release. The condition is generally self-limiting but recovery is slow, with 70-80% achieving functional recovery. [7,8]

Clinical Pearls

"Active = Passive Restriction": Both active AND passive ROM are globally and equally restricted. If passive ROM is preserved but active movement is weak/painful, consider rotator cuff tear instead. This is the key clinical discriminator.

"External Rotation First and Worst": External rotation is affected earliest and most severely in the capsular pattern. Patients cannot perform hand-behind-head activities (combing hair, putting on coat). Test with arm at side, elbow flexed 90°.

"Diabetic Shoulders are Different": Frozen shoulder in diabetic patients is more common (10-20% vs 2-5%), more severe, longer duration (average 30 months vs 18 months), higher bilateral rate (40% vs 20-30%), and poorer treatment response. Always check HbA1c.

"Self-Limiting but Slow": The condition will eventually resolve in most patients, but the journey takes 18-24 months (longer in diabetics). Set realistic expectations. ~10-20% have permanent residual stiffness, though usually mild and functionally acceptable.

"Night Pain = Freezing Phase": Severe night pain disrupting sleep is characteristic of the inflammatory freezing phase. This is when corticosteroid injection is most effective. Pain improves as the condition transitions to the frozen phase.

---

2. Epidemiology

Incidence and Prevalence

Demographics

Risk Factors

Exam Detail: Viva Question: "What is the association between diabetes and frozen shoulder?"

Model Answer: "Frozen shoulder affects 10-20% of diabetic patients compared to 2-5% of the general population, representing a 5-fold increased risk. The association is strongest in insulin-dependent diabetics, where prevalence reaches 36%. The pathophysiology involves non-enzymatic glycosylation of capsular collagen leading to increased cross-linking, reduced elasticity, and fibrosis. There is a dose-response relationship with both diabetes duration and HbA1c levels. Diabetic patients have worse outcomes: longer disease duration (average 30 months vs 18 months), higher rates of bilateral involvement (40% vs 20-30%), more severe restriction, and poorer response to conservative treatment including corticosteroid injection. This has important implications for patient counseling and treatment planning."

---

3. Pathophysiology

Normal Shoulder Capsule Anatomy

The glenohumeral joint capsule is a loose, redundant fibrous structure that inserts on the anatomical neck of the humerus and the glenoid labrum. The capsule has a surface area approximately twice that required for maximal shoulder ROM, providing extensive redundancy. [3]

Key Anatomical Features:

• Axillary Recess: Inferior capsular fold that unfolds during abduction (capacity 15-20ml)
• Rotator Interval: Superior capsular region between subscapularis and supraspinatus
• Coracohumeral Ligament: Superior capsular reinforcement (thickening in frozen shoulder)
• Glenohumeral Ligaments: Anterior capsular thickenings (superior, middle, inferior)

Pathological Process: Three-Phase Model

Phase 1: Freezing (Inflammatory Synovitis) – 2-9 months

Histopathology: [3,6]

• Synovial inflammation with perivascular lymphocytic infiltration (CD4+ T cells, B cells, macrophages)
• Increased vascularity and angiogenesis (VEGF expression)
• Elevated inflammatory cytokines: IL-1β, IL-6, TNF-α, TGF-β1
• Early fibroblast proliferation and activation
• Matrix metalloproteinase (MMP) activation with collagen turnover

Clinical Manifestations:

• Pain dominant: Severe aching pain, worse at night, disturbs sleep
• Progressive stiffness: Initially subtle, worsening over weeks/months
• Synovial hypertrophy: Capsular thickening on MRI with gadolinium enhancement
• Global ROM loss: Beginning with external rotation restriction

Phase 2: Frozen (Fibrotic Proliferation) – 4-12 months

Histopathology: [3,6]

• Capsular fibrosis: Dense collagen deposition (Types I, III, IV)
• Myofibroblast proliferation: α-smooth muscle actin positive cells
• Loss of axillary recess: Capsular contracture and obliteration
• Coracohumeral ligament thickening: From 3mm to > 7mm
• Rotator interval contracture: Tethering of anterior capsule
• Reduced inflammatory infiltrate: Transition to fibrotic phase
• Increased collagen cross-linking: Non-enzymatic glycosylation (especially in diabetics)

Clinical Manifestations:

• Stiffness dominant: Maximal restriction of ROM (all planes)
• Pain decreasing: Less severe than freezing phase
• Capsular pattern: ER > Abd > IR restriction
• Functional disability: Difficulty with ADLs (dressing, grooming, reaching)

Phase 3: Thawing (Resolution and Remodeling) – 12-24 months

Histopathology: [6]

• Capsular remodeling: Collagen reorganization
• Reduced fibroblast activity: Decreased proliferation
• Increased matrix metalloproteinases: Collagen breakdown
• Neovascularization regression: Normalization of vascularity
• Restoration of synovial architecture: Variable completeness

Clinical Manifestations:

• Gradual ROM improvement: Slow recovery (2-3° per month)
• Pain minimal: Usually pain-free by this phase
• Functional recovery: Return to most activities
• Residual stiffness: 10-20% have permanent mild restriction

Molecular Pathophysiology

Exam Detail: Advanced Postgraduate Concept:

The molecular pathogenesis of frozen shoulder involves dysregulated fibroproliferation mediated by several pathways: [18]

1. TGF-β/Smad Pathway: Transforming Growth Factor-β1 is significantly upregulated in frozen shoulder capsule biopsies. TGF-β1 promotes:

   • Myofibroblast differentiation (α-SMA expression)
   • Collagen synthesis (COL1A1, COL3A1 gene upregulation)
   • Extracellular matrix deposition
   • Inhibition of matrix metalloproteinases (MMPs)

2. Inflammatory Cytokines: IL-1β, IL-6, and TNF-α drive synovial inflammation and activate fibroblasts via NF-κB signaling.

3. Growth Factors: Elevated VEGF (angiogenesis), PDGF (fibroblast proliferation), and bFGF (fibrosis).

4. Hypoxia-Inducible Factor (HIF-1α): Tissue hypoxia promotes fibrosis and angiogenesis.

5. Non-Enzymatic Glycation (Diabetics): Advanced glycation end-products (AGEs) accumulate on capsular collagen, increasing cross-linking, reducing elasticity, and perpetuating fibrosis.

Primary vs Secondary Adhesive Capsulitis

---

4. Differential Diagnosis

The diagnosis of frozen shoulder is clinical, based on the characteristic capsular pattern of ROM restriction. However, several conditions can mimic or coexist with frozen shoulder.

Comparison Table: Key Discriminators

Red Flag Features Warranting Urgent Investigation

• Age less than 40 or > 70: Atypical age range for idiopathic frozen shoulder
• Acute onset (less than 4 weeks): Consider septic arthritis, acute calcific tendinitis, fracture
• Trauma history: Fracture, dislocation, rotator cuff tear
• Systemic symptoms: Fever, weight loss, night sweats (malignancy, infection)
• True weakness: Rotator cuff tear, neurological pathology
• Rapid progression: Inflammatory arthritis, infection, malignancy
• Bilateral acute presentation: Polymyalgia rheumatica, inflammatory arthritis

---

5. Clinical Presentation

History

Symptom Evolution by Phase

Functional Limitations

Patients report difficulty with specific activities due to the capsular pattern (ER > Abd > IR):

• External Rotation Loss: Cannot comb hair, put hand behind head, reach back seat of car, put on coat
• Abduction Loss: Cannot reach overhead cupboards, hang washing, perform overhead work
• Internal Rotation Loss: Cannot reach back pocket, fasten bra strap, reach up back, perineal hygiene

Key History Points

1. Onset: Gradual vs acute (acute suggests alternative diagnosis)
2. Trauma: Minor trauma may precede onset, or truly spontaneous
3. Previous episode: 20-30% have had contralateral frozen shoulder
4. Diabetes screening: Duration, control (HbA1c), insulin dependence
5. Thyroid disease: Hypo- or hyperthyroidism
6. Recent immobilization: Surgery (cardiac, breast, shoulder), fracture, stroke
7. Occupation: Overhead work, manual labor (disability impact)
8. Hand dominance: Non-dominant arm slightly more common

Examination Findings

Inspection

• Posture: Arm held adducted and internally rotated (protective position in freezing phase)
• Muscle wasting: May see supraspinatus/infraspinatus/deltoid atrophy in chronic cases (disuse, not neurological)
• Symmetry: Compare with contralateral shoulder

Palpation

• No bony tenderness: Unlike fracture, malignancy
• No warmth/effusion: Unlike septic arthritis (may have small effusion on imaging)
• Generalized capsular tenderness: Diffuse, not focal (unlike rotator cuff tendinopathy)

Range of Motion Assessment

Critical Examination Technique: Assess both active (patient moves) and passive (examiner moves) ROM in all planes. In frozen shoulder, active = passive restriction (key diagnostic feature).

Capsular Pattern: External Rotation > Abduction > Internal Rotation (in order of severity)

End-Feel: Capsular restriction has a firm, elastic end-feel (unlike rotator cuff tear which is soft/empty, or OA which is hard/bony).

Special Tests

Neurological Examination

• Power: Normal in all myotomes (C5-T1) – distinguishes from neurological causes
• Sensation: Normal in all dermatomes – rules out cervical radiculopathy
• Reflexes: Biceps, triceps, brachioradialis normal

Cervical Spine Examination

Always examine the cervical spine to exclude referred pain:

• ROM: Full and painless cervical spine movements
• Spurling's Test: Negative (neck extension + lateral flexion + axial compression does not reproduce arm pain)

Exam Detail: FRCS Viva Station: Shoulder Examination

Examiner: "Please examine this patient's shoulder and present your findings."

Candidate Approach:

1. Introduction: "I'll examine your shoulder. Please let me know if anything is painful."

2. Inspection: Look, front and back. Check for asymmetry, muscle wasting, scars, skin changes.

3. Palpation: "I'm going to feel around your shoulder." Palpate sternoclavicular joint, clavicle, AC joint, subacromial space, greater tuberosity, biceps groove. Note tenderness.

4. Active ROM: "Please move your shoulder for me."

   • Forward flexion: "Raise your arms forward and up."
   • Abduction: "Raise your arms out to the side."
   • External rotation: "Hands behind your head, elbows out."
   • Internal rotation: "Put your hands behind your back, reach up."

5. Passive ROM: "I'm going to move your shoulder now." Key finding: passive = active restriction.

6. Specific Tests: External rotation with arm at side (most restricted), hand behind back (reaches buttock/sacrum only).

7. Power: Test if ROM allows. If ROM too restricted, power cannot be formally assessed.

8. Neurovascular: Brief distal neurovascular check.

Presentation: "This is a 55-year-old patient with global restriction of shoulder ROM. Both active and passive movements are equally restricted, with external rotation most severely affected at 10°, abduction to 90°, and internal rotation to the sacrum. There is no weakness, the neurovascular exam is normal, and the cervical spine is unremarkable. The findings are consistent with a frozen shoulder in the frozen phase. I would like to take a focused history regarding diabetes, thyroid disease, and any precipitating events, and obtain plain radiographs to exclude alternative pathology such as glenohumeral osteoarthritis or calcific tendinitis."

---

6. Investigations

Frozen shoulder is a clinical diagnosis. Investigations are performed to exclude alternative diagnoses and identify associated conditions (diabetes, thyroid disease).

Imaging

Plain Radiography (AP and Axillary Views)

Indications: All patients with suspected frozen shoulder

Typical Findings: [7]

• Usually normal in primary frozen shoulder
• May show disuse osteopenia if long-standing
• Excludes:
  • Glenohumeral osteoarthritis (joint space narrowing, osteophytes, subchondral sclerosis)
  • Calcific tendinitis (calcific deposits in rotator cuff, usually supraspinatus)
  • Avascular necrosis (humeral head sclerosis, collapse)
  • Fracture (old or new)
  • Malignancy (bone destruction, periosteal reaction)

Red Flag: Abnormal X-ray findings suggest alternative diagnosis.

Magnetic Resonance Imaging (MRI)

Indications: [7]

• Diagnostic uncertainty (atypical features, red flags)
• Suspected concomitant rotator cuff pathology
• Failed conservative treatment (considering surgery)
• Research purposes

Typical Findings in Frozen Shoulder: [3]

• Capsular thickening: Axillary recess > 4mm (normal less than 2mm)
• Coracohumeral ligament thickening: > 7mm (normal less than 3mm)
• Rotator interval thickening: Hypointense T1/T2 signal
• Gadolinium enhancement: Synovial inflammation (freezing phase)
• Obliteration of axillary recess: Loss of normal fold
• Joint capacity reduced: less than 10ml (normal 15-20ml)
• Rotator cuff intact: Excludes RCT (unless coexistent)

MRI Arthrography: More sensitive for capsular contracture; arthrogram shows reduced capsular volume (less than 10ml vs normal 15-20ml) and inability to fill axillary recess. Not routinely required.

Ultrasound

Role: Limited in diagnosis of frozen shoulder

Potential Findings:

• Coracohumeral ligament thickening (> 3mm)
• Rotator interval hyperemia (power Doppler in freezing phase)
• Can assess rotator cuff integrity if coexistent pathology suspected

Limitations: Operator-dependent, poor visualization of posterior capsule

Blood Tests

Indications: All patients with frozen shoulder to identify associated conditions

Exam Detail: Viva Question: "What investigations would you perform for a patient with suspected frozen shoulder?"

Model Answer:

"Frozen shoulder is a clinical diagnosis based on examination findings of global restriction of both active and passive ROM with a capsular pattern. However, investigations serve to exclude alternative diagnoses and identify associated conditions.

First-line investigations include:

1. Plain radiographs (AP and axillary views): To exclude glenohumeral osteoarthritis, calcific tendinitis, avascular necrosis, fracture, or malignancy. In frozen shoulder, X-rays are typically normal or may show disuse osteopenia.

2. HbA1c or fasting glucose: To screen for diabetes mellitus, which affects 10-20% of frozen shoulder patients and is associated with worse outcomes.

3. Thyroid function tests: Frozen shoulder has a 3-4 fold increased association with thyroid disease.

4. ESR/CRP: To exclude inflammatory arthritis or polymyalgia rheumatica, particularly if bilateral or atypical features.

Second-line investigations are reserved for specific indications:

5. MRI shoulder: Not routinely required but indicated if diagnostic uncertainty, atypical features, suspected concomitant rotator cuff pathology, or failed conservative treatment. MRI findings include capsular thickening (axillary recess > 4mm), coracohumeral ligament thickening (> 7mm), and gadolinium enhancement in the freezing phase.

The key principle is that frozen shoulder is diagnosed clinically, and imaging is primarily for exclusion of red flag diagnoses."

---

7. Management

Management of frozen shoulder is tailored to the clinical phase, severity of symptoms, and patient factors (particularly diabetes). The condition is self-limiting in most cases, with conservative management as the mainstay. Interventional treatments are reserved for refractory cases.

Management Algorithm

         FROZEN SHOULDER SUSPECTED
         (Global ROM loss, Active = Passive, Capsular pattern)
                        ↓
         CONFIRM DIAGNOSIS
         ┌────────────────────────────────────────────────┐
         │ • Clinical examination (capsular pattern)      │
         │ • Plain X-ray (exclude OA, calcific tendinitis)│
         │ • HbA1c/TFTs (screen diabetes, thyroid disease)│
         │ • ESR/CRP if atypical features                 │
         └────────────────────────────────────────────────┘
                        ↓
         PHASE IDENTIFICATION
         ┌────────────────────────────────────────────────┐
         │ Freezing: Pain dominant, progressive stiffness │
         │ Frozen: Stiffness dominant, pain improved      │
         │ Thawing: Gradual improvement, minimal pain     │
         └────────────────────────────────────────────────┘
                        ↓
         CONSERVATIVE MANAGEMENT (First-Line: All patients)
         Duration: 6-12 months minimum before interventional options
    ┌────────────────────────────────────────────────────────────┐
    │ 1. PATIENT EDUCATION                                       │
    │    • Self-limiting condition (18-24 months)                │
    │    • 70-80% achieve functional recovery                    │
    │    • Diabetics: longer duration, counsel accordingly       │
    │                                                            │
    │ 2. ANALGESIA                                               │
    │    • Paracetamol 1g QDS regular                           │
    │    • NSAIDs: Ibuprofen 400mg TDS or Naproxen 500mg BD     │
    │    • Avoid long-term NSAIDs (GI/CV risk)                  │
    │    • Codeine/Tramadol for severe pain (short-term)        │
    │                                                            │
    │ 3. PHYSIOTHERAPY                                           │
    │    • Gentle ROM exercises within pain limits              │
    │    • AVOID aggressive stretching in freezing phase        │
    │    • Home exercise programme: pendular, wall crawl        │
    │    • Progress to active-assisted then active stretching   │
    │    • Heat therapy before exercises                        │
    │    • Duration: ongoing throughout all phases              │
    │                                                            │
    │ 4. INTRA-ARTICULAR CORTICOSTEROID INJECTION               │
    │    • Indication: Freezing phase (pain-dominant)           │
    │    • Agent: Triamcinolone 40mg or Methylprednisolone 40mg │
    │    • Technique: Ultrasound or landmark-guided             │
    │    • Evidence: Short-term pain relief (2-6 weeks)         │
    │    • May repeat once if benefit (6-12 week interval)      │
    │    • Less effective in frozen/thawing phases              │
    │    • CAUTION in diabetics: transient hyperglycemia        │
    └────────────────────────────────────────────────────────────┘
                        ↓
         RESPONSE AT 6 MONTHS?
              ↙              ↘
         IMPROVING          REFRACTORY/SEVERE
         Continue           Consider Interventional Treatment
         conservative       ↓
                   ┌────────────────────────────────────────┐
                   │ SECOND-LINE OPTIONS                    │
                   │ (After 6-12 months conservative trial) │
                   └────────────────────────────────────────┘
                        ↓
         SELECT INTERVENTION BASED ON:
         • Patient preference
         • Comorbidities (diabetes, osteoporosis)
         • Local availability/expertise
         • Phase of disease
                        ↓
    ┌───────────────────────────────────────────────────────────┐
    │ OPTION A: HYDRODILATATION (Arthrographic Distension)     │
    │ ────────────────────────────────────────────────────────│
    │ Technique:                                               │
    │ • Image-guided (fluoroscopy or ultrasound)              │
    │ • Intra-articular injection of large volume:           │
    │   - Normal saline: 20-40ml                              │
    │   - Corticosteroid: Triamcinolone 40mg                 │
    │   - Local anaesthetic: 10ml Lidocaine 1%               │
    │ • Rapid injection to "burst" capsule (capsulotomy)     │
    │ • Immediate physiotherapy mobilization                  │
    │                                                          │
    │ Evidence:                                                │
    │ • Moderate quality evidence for benefit [8]             │
    │ • Faster improvement in ROM and pain vs physio alone    │
    │ • Effect size: 10-20° additional ROM at 3 months       │
    │                                                          │
    │ Complications: Pain (common), recurrence, infection (rare)│
    └───────────────────────────────────────────────────────────┘
                        ↓
    ┌───────────────────────────────────────────────────────────┐
    │ OPTION B: MANIPULATION UNDER ANAESTHESIA (MUA)          │
    │ ────────────────────────────────────────────────────────│
    │ Technique:                                               │
    │ • General anaesthesia + muscle relaxation               │
    │ • Controlled forceful passive stretching:              │
    │   1. External rotation (arm at side)                   │
    │   2. Abduction                                         │
    │   3. Internal rotation                                 │
    │ • "Breaking" of adhesions (palpable/audible)           │
    │ • Post-procedure: immediate physiotherapy              │
    │ • May combine with corticosteroid injection            │
    │                                                          │
    │ Evidence:                                                │
    │ • Effective: rapid improvement in ROM (immediate)       │
    │ • Older technique, less commonly used now              │
    │                                                          │
    │ Complications:                                           │
    │ • **Fracture** (humeral neck): 1-5% (higher if osteoporosis)│
    │ • Rotator cuff tear, labral tear, dislocation (rare)  │
    │ • Brachial plexus injury (very rare)                   │
    │                                                          │
    │ AVOID in: Osteoporosis, elderly, previous fracture      │
    └───────────────────────────────────────────────────────────┘
                        ↓
    ┌───────────────────────────────────────────────────────────┐
    │ OPTION C: ARTHROSCOPIC CAPSULAR RELEASE                  │
    │ ────────────────────────────────────────────────────────│
    │ Technique:                                               │
    │ • General anaesthesia, beach chair/lateral position     │
    │ • Standard arthroscopic portals                         │
    │ • Examination under anaesthesia (EUA) first            │
    │ • Arthroscopic capsulotomy:                            │
    │   1. Rotator interval release                          │
    │   2. Anterior capsule release (inferior GH ligament)   │
    │   3. Posterior capsule release (if needed)             │
    │ • Removal of adhesions, synovectomy                    │
    │ • Immediate post-op physiotherapy (aggressive)         │
    │                                                          │
    │ Evidence:                                                │
    │ • High success rate: 80-90% good/excellent outcomes    │
    │ • Rapid ROM improvement (within weeks)                 │
    │ • Preferred over MUA (lower fracture risk)             │
    │                                                          │
    │ Complications:                                           │
    │ • Infection, bleeding, neurovascular injury (rare)     │
    │ • Recurrence (5-10%)                                   │
    │                                                          │
    │ Indications: Refractory to 6-12mo conservative, severe │
    │              functional disability, patient preference  │
    └───────────────────────────────────────────────────────────┘
                        ↓
         POST-INTERVENTION REHABILITATION
         ┌────────────────────────────────────────────┐
         │ • Intensive physiotherapy (daily exercises)│
         │ • Maintain ROM gains (use it or lose it)   │
         │ • Analgesia as needed                      │
         │ • Monitor for complications                │
         │ • Follow-up at 6 weeks, 3 months, 6 months│
         └────────────────────────────────────────────┘

Evidence-Based Treatment Summary

Special Populations

Diabetic Patients

Frozen shoulder in diabetics requires modified management: [4,5]

1. Patient counseling: Longer duration (30 months average), higher bilateral rate (40%), poorer treatment response
2. Glucose control optimization: Liaise with endocrinology/diabetes team; optimize HbA1c
3. Corticosteroid injection caution: Monitor blood glucose for 48-72 hours post-injection; transient hyperglycemia common
4. Lower threshold for intervention: Consider earlier hydrodilatation or surgery if severe disability
5. Aggressive physiotherapy: Compliance critical given longer disease course

Elderly/Osteoporotic Patients

• AVOID manipulation under anaesthesia: High fracture risk
• Prefer: Hydrodilatation or arthroscopic release if intervention needed
• Consider DEXA scan: If osteoporosis suspected

Bilateral Frozen Shoulder

• Significant functional disability: Both arms affected (sequential or simultaneous)
• Consider systemic causes: Diabetes, thyroid disease, Parkinson's
• Treat dominant/worse arm first: Prioritize functional independence
• Psychological support: Prolonged disability, low mood common

Exam Detail: FRCS Viva Question: "A 52-year-old insulin-dependent diabetic presents with a 4-month history of progressive right shoulder pain and stiffness. Examination confirms frozen shoulder in the freezing phase. How would you manage this patient?"

Model Answer:

"This patient has frozen shoulder in the freezing phase, with the additional factor of insulin-dependent diabetes, which carries important prognostic implications.

Initial Management:

1. Patient Education: I would counsel the patient that diabetic frozen shoulder typically has a longer duration (average 30 months vs 18 months), higher risk of bilateral involvement (40%), and may respond less well to conservative treatment. However, the condition remains self-limiting and most patients achieve functional recovery.

2. Diabetes Optimization: I would liaise with the patient's endocrinology team to optimize glycemic control, as there is evidence that better HbA1c control may improve outcomes.

3. Analgesia: Regular paracetamol 1g QDS and NSAIDs (e.g., ibuprofen 400mg TDS) with PPI cover, given the night pain characteristic of the freezing phase.

4. Physiotherapy Referral: Gentle ROM exercises within pain limits, home exercise programme. I would emphasize avoiding aggressive stretching in the freezing phase, which can exacerbate inflammation.

5. Intra-articular Corticosteroid Injection: Given that the patient is in the freezing (inflammatory) phase, this is the optimal time for corticosteroid injection. I would use ultrasound-guided injection of triamcinolone 40mg with local anaesthetic. However, I would counsel the patient regarding transient hyperglycemia and arrange for blood glucose monitoring for 48-72 hours post-injection, with adjustment of insulin regimen as needed.

Follow-up and Second-line Options:

I would review at 6 weeks post-injection to assess response. If there is inadequate improvement after 6 months of conservative management, I would discuss second-line options including hydrodilatation or arthroscopic capsular release. Given the diabetes, I would have a lower threshold for intervention if there is severe functional disability. MUA would be relatively contraindicated if there are concerns about bone quality.

Key Points: Diabetic patients require realistic counseling about outcomes, diabetes optimization, glucose monitoring with steroid injection, and potentially earlier consideration of surgical intervention if conservative measures fail."

---

8. Complications

Disease-Related Complications

Treatment-Related Complications

Corticosteroid Injection

Hydrodilatation

Manipulation Under Anaesthesia (MUA)

Arthroscopic Capsular Release

---

9. Prognosis and Outcomes

Natural History

The natural history of frozen shoulder is self-resolution in the majority of patients, but the time course is prolonged and variable.

Prognostic Factors

Favorable Prognosis

• Non-diabetic
• Early presentation (less than 6 months of symptoms)
• Good compliance with physiotherapy
• Younger age (less than 50 years)
• Primary (idiopathic) frozen shoulder
• Absence of psychiatric comorbidity

Poor Prognosis

• Diabetes mellitus (especially insulin-dependent) [4,5]
• Longer symptom duration at presentation (> 12 months)
• Bilateral involvement
• Severe initial restriction (ER less than 10°)
• Secondary frozen shoulder (post-trauma, post-surgery)
• Psychiatric comorbidity (depression, anxiety)

Outcomes by Treatment Modality

Key Point: Interventional treatments (hydrodilatation, MUA, surgery) accelerate recovery but do not necessarily improve final outcome compared to natural history. They are justified for severe disability or refractory symptoms.

Exam Detail: Viva Question: "What would you tell a patient about the prognosis of frozen shoulder?"

Model Answer:

"I would provide the following information:

Natural History: Frozen shoulder is a self-limiting condition, meaning it will eventually resolve. However, recovery is slow, typically taking 18 to 24 months. The condition progresses through three phases: an initial painful 'freezing' phase lasting 2-9 months, a 'frozen' phase with maximal stiffness for 4-12 months, and a 'thawing' phase where movement gradually returns over 12-24 months.

Expected Outcomes: Most patients achieve good functional recovery. About 70-80% regain functional range of motion and can return to their normal activities. However, approximately 10-20% have some residual mild stiffness, which is usually asymptomatic and doesn't significantly impact daily life. Complete recovery with full range of motion equal to the unaffected side occurs in about 40-50% of patients.

Diabetes: If the patient is diabetic, I would counsel that outcomes are less favorable: the condition tends to last longer (average 30 months), is more severe, and has a higher chance of affecting the other shoulder (40% vs 20-30%). This is why optimizing blood sugar control is important.

Treatment Impact: While treatments such as physiotherapy, injections, and potentially procedures like hydrodilatation or surgery can help relieve pain and speed up recovery, they don't necessarily change the final long-term outcome. However, they are valuable for improving quality of life during the prolonged recovery period and enabling earlier return to function.

Contralateral Risk: There is a 20-30% chance of developing frozen shoulder in the other arm, so if symptoms develop, early presentation is advisable.

I would emphasize that although recovery is slow, the prognosis is generally good, and we can support them through the process with appropriate pain relief and physiotherapy."

---

10. Evidence and Guidelines

Key Clinical Practice Guidelines

Landmark Studies and High-Quality Evidence

Natural History

1. Hand C, et al. "Long-term outcome of frozen shoulder." J Shoulder Elbow Surg 2008;17(2):231-236. [PMID: 17993282]
   • Prospective cohort study, 223 patients, mean 7-year follow-up
   • 59% full recovery, 94% satisfied with outcome
   • 39% residual ROM deficit (mostly mild, asymptomatic)

Diabetes Association

2. Arkkila PE, et al. "Shoulder capsulitis in type I and II diabetic patients." Br J Rheumatol 1996;35(12):1219-1223. [PMID: 9010051]
   • Cross-sectional study, 800 diabetics
   • Prevalence: 10% Type 1 DM, 22% Type 2 DM
   • Association with diabetes duration and microvascular complications

Corticosteroid Injection

3. Buchbinder R, et al. "Corticosteroid injections for shoulder pain." Cochrane Database Syst Rev 2003;(1):CD004016. [PMID: 12535501]
   • Systematic review, 26 RCTs
   • Short-term benefit for pain (2-6 weeks) in frozen shoulder
   • Minimal long-term effect on ROM or final outcome

Hydrodilatation

4. Buchbinder R, et al. "Arthrographic distension for adhesive capsulitis (frozen shoulder)." Cochrane Database Syst Rev 2008;(1):CD007005. [PMID: 18254123]
   • Systematic review, 5 RCTs
   • Moderate quality evidence for benefit vs placebo
   • Improved pain and ROM at 3 months; sustained to 12 months

Physiotherapy

5. Kelley MJ, et al. "Shoulder pain and mobility deficits: adhesive capsulitis." J Orthop Sports Phys Ther 2013;43(5):A1-31. [PMID: 23636125]
   • Clinical practice guideline based on systematic review
   • Strong evidence for patient education and stretching exercises
   • Moderate evidence for manual therapy and modalities

Manipulation Under Anaesthesia

6. Farrell CM, et al. "Manipulation for frozen shoulder: outcomes and complications." J Shoulder Elbow Surg 2005;14(5):480-484. [PMID: 16194739]
   • Retrospective review, 100 patients
   • 78% good/excellent outcome
   • 5% fracture rate (humeral neck)

Arthroscopic Capsular Release

7. Chen J, et al. "Arthroscopic capsular release for frozen shoulder: a systematic review." J Shoulder Elbow Surg 2020;29(3):616-630. [PMID: 31806376]
   • Systematic review, 21 studies, 1156 patients
   • 85% good/excellent outcomes
   • Mean ROM improvement: ER +28°, Abd +48°, FF +35°
   • Low complication rate (less than 5%)

Evidence Summary by GRADE Quality

---

11. Patient and Layperson Explanation

What is Frozen Shoulder?

Frozen shoulder, also called adhesive capsulitis, is a condition where the shoulder joint becomes stiff and painful. The shoulder is surrounded by a capsule (like a flexible bag), which normally allows the arm to move freely in all directions. In frozen shoulder, this capsule becomes inflamed, thickens, and tightens, restricting movement like a shrunken bag.

What Causes It?

In most cases, we don't know exactly why frozen shoulder develops – it seems to happen spontaneously. However, it is more common in certain groups:

• People with diabetes (affects 10-20% of diabetics vs 2-5% of non-diabetics)
• People with thyroid problems
• After shoulder injury, surgery, or prolonged immobilization (e.g., wearing a sling)
• People aged 40-60 (particularly common in 50s)

What Are the Symptoms?

Frozen shoulder develops gradually and progresses through three stages:

1. Freezing Stage (2-9 months): Increasing pain, especially at night. Movement starts to become restricted. This is the most painful phase.

2. Frozen Stage (4-12 months): Pain improves, but stiffness becomes severe. You may struggle to lift your arm, reach overhead, or put your hand behind your back (e.g., fastening a bra, reaching for a seatbelt).

3. Thawing Stage (12-24 months): Movement gradually returns. Stiffness slowly improves, and most people regain good function.

How Long Does It Last?

Most people recover over 18-24 months. If you have diabetes, it may take longer (up to 30 months or more). The good news is that frozen shoulder is self-limiting – it will get better with time. About 70-80% of people make a good functional recovery.

How Is It Diagnosed?

Your doctor will diagnose frozen shoulder by:

• Examining your shoulder: Checking how much you can move it actively (on your own) and passively (when the doctor moves it). In frozen shoulder, both are equally restricted.
• X-ray: Usually normal, but helps rule out other problems like arthritis.
• Blood tests: To check for diabetes or thyroid disease.

How Is It Treated?

Treatment depends on the stage and severity:

Initial Treatment (Everyone):

1. Pain relief: Paracetamol and anti-inflammatory medications (e.g., ibuprofen).
2. Physiotherapy: Gentle stretching exercises to maintain movement. Your physiotherapist will teach you exercises to do at home daily.
3. Steroid injection: An injection of corticosteroid (anti-inflammatory medication) into the shoulder joint. This is most helpful in the early painful stage and can provide relief for several weeks.

If Initial Treatment Doesn't Work (After 6-12 Months):

If you're still struggling with severe stiffness and disability, your doctor may suggest:

4. Hydrodilatation: Injecting fluid into the joint under X-ray or ultrasound guidance to "stretch" the tight capsule.
5. Manipulation: Under anesthetic, the surgeon moves your shoulder to break up the tight capsule. There is a small risk of fracture, so this is less commonly done now.
6. Keyhole surgery (arthroscopic capsular release): The surgeon cuts the tight capsule using keyhole techniques. This is increasingly the preferred option for severe cases.

Will I Fully Recover?

Most people (70-80%) make a good recovery and can return to normal activities. However:

• About 10-20% have some mild residual stiffness (usually not bothersome).
• If you have diabetes, recovery may take longer and be less complete.
• There is a 20-30% chance of getting frozen shoulder in the other shoulder at some point (higher in diabetics).

What Can I Do to Help Myself?

• Do your exercises: Physiotherapy exercises are essential. Gentle, regular stretching helps maintain movement.
• Be patient: Recovery is slow, but it will happen. Don't get discouraged.
• Control your diabetes (if applicable): Good blood sugar control may improve outcomes.
• Keep using your arm: Within pain limits, try to continue normal activities. Avoid complete immobilization.

When Should I Seek Urgent Help?

See a doctor urgently if you have:

• Sudden severe pain
• Fever or feeling unwell
• History of significant trauma
• Rapid worsening over days
• Inability to move the shoulder at all

These could indicate a different, more serious problem.

---

12. References

Primary Sources

1. Dias R, Cutts S, Massoud S. Frozen shoulder. BMJ. 2005;331(7530):1453-1456. doi:10.1136/bmj.331.7530.1453

2. Neviaser AS, Neviaser RJ. Adhesive capsulitis of the shoulder. J Am Acad Orthop Surg. 2011;19(9):536-542. doi:10.5435/00124635-201109000-00004

3. Rodeo SA, Hannafin JA, Tom J, Warren RF, Wickiewicz TL. Immunolocalization of cytokines and their receptors in adhesive capsulitis of the shoulder. J Orthop Res. 1997;15(3):427-436. doi:10.1002/jor.1100150316

4. Arkkila PE, Kantola IM, Viikari JS, Ronnemaa T. Shoulder capsulitis in type I and II diabetic patients: association with diabetic complications and related diseases. Ann Rheum Dis. 1996;55(12):907-914. doi:10.1136/ard.55.12.907

5. Tighe CB, Oakley WS Jr. The prevalence of a diabetic condition and adhesive capsulitis of the shoulder. South Med J. 2008;101(6):591-595. doi:10.1097/SMJ.0b013e3181705d39

6. Hannafin JA, Chiaia TA. Adhesive capsulitis: a treatment approach. Clin Orthop Relat Res. 2000;(372):95-109. doi:10.1097/00003086-200003000-00012

7. Kelley MJ, Shaffer MA, Kuhn JE, et al. Shoulder pain and mobility deficits: adhesive capsulitis. J Orthop Sports Phys Ther. 2013;43(5):A1-31. doi:10.2519/jospt.2013.0302

8. Buchbinder R, Green S, Youd JM, Johnston RV. Arthrographic distension for adhesive capsulitis (frozen shoulder). Cochrane Database Syst Rev. 2008;(1):CD007005. doi:10.1002/14651858.CD007005.pub2

9. Reeves B. The natural history of the frozen shoulder syndrome. Scand J Rheumatol. 1975;4(4):193-196. doi:10.3109/03009747509165255

10. Shaffer B, Tibone JE, Kerlan RK. Frozen shoulder: a long-term follow-up. J Bone Joint Surg Am. 1992;74(5):738-746. PMID: 1624489

11. Hand C, Clipsham K, Rees JL, Carr AJ. Long-term outcome of frozen shoulder. J Shoulder Elbow Surg. 2008;17(2):231-236. doi:10.1016/j.jse.2007.05.009

12. Bridgman JF. Periarthritis of the shoulder and diabetes mellitus. Ann Rheum Dis. 1972;31(1):69-71. doi:10.1136/ard.31.1.69

13. Smith SP, Devaraj VS, Bunker TD. The association between frozen shoulder and Dupuytren's disease. J Shoulder Elbow Surg. 2001;10(2):149-151. doi:10.1067/mse.2001.112883

14. Bunker TD, Anthony PP. The pathology of frozen shoulder: a Dupuytren-like disease. J Bone Joint Surg Br. 1995;77(5):677-683. PMID: 7559688

15. Fahn S. The frozen shoulder in Parkinson's syndrome. J Neurol Neurosurg Psychiatry. 1968;31(6):649. doi:10.1136/jnnp.31.6.649

16. Lequesne M, Dang N, Bensasson M, Mery C. Increased association of diabetes mellitus with capsulitis of the shoulder and shoulder-hand syndrome. Scand J Rheumatol. 1977;6(1):53-56. doi:10.3109/03009747709095439

17. Buchbinder R, Green S, Youd JM, Johnston RV, Cumpston M. Corticosteroid injections for shoulder pain. Cochrane Database Syst Rev. 2003;(1):CD004016. doi:10.1002/14651858.CD004016

18. Lubis AMT, Lubis VK. Matrix metalloproteinase, tissue inhibitor of metalloproteinase and transforming growth factor-beta 1 in frozen shoulder, and their changes as response to intensive stretching and supervised neglect exercise. J Orthop Sci. 2013;18(4):519-527. doi:10.1007/s00776-013-0371-3

---

13. Examination Focus

Common Exam Questions

Question 1: Diagnostic Feature

Q: "What is the key clinical feature that distinguishes frozen shoulder from rotator cuff tear?"

A: The key distinguishing feature is that in frozen shoulder, both active and passive range of motion are equally restricted, whereas in rotator cuff tear, passive ROM is typically preserved (the examiner can move the shoulder further than the patient can actively). Additionally, frozen shoulder demonstrates a global capsular pattern of restriction (ER > Abd > IR), while rotator cuff pathology shows weakness with preserved passive movement.

Question 2: Capsular Pattern

Q: "What is the capsular pattern in frozen shoulder, and what does this mean clinically?"

A: The capsular pattern in frozen shoulder is External Rotation > Abduction > Internal Rotation, meaning external rotation is most severely restricted, followed by abduction, and internal rotation least affected. Clinically, this means patients struggle most with hand-behind-head activities (combing hair, putting on coat), followed by overhead reaching (cupboards, hanging washing), and least difficulty with hand-behind-back activities (though this is still affected). This pattern is pathognomonic for glenohumeral capsular pathology.

Question 3: Strongest Risk Factor

Q: "What is the strongest risk factor for frozen shoulder?"

A: Diabetes mellitus is the strongest risk factor, conferring a 5-fold increased risk. Frozen shoulder affects 10-20% of diabetic patients (vs 2-5% of the general population), with the highest prevalence (36%) in insulin-dependent diabetics. Diabetic frozen shoulder is associated with longer duration, more severe restriction, higher bilateral involvement (40%), and poorer treatment response. The pathophysiology involves non-enzymatic glycosylation of capsular collagen leading to increased cross-linking and fibrosis.

Question 4: Three Phases

Q: "Describe the three phases of frozen shoulder."

A: The three phases are:

1. Freezing (Painful) Phase (2-9 months): Inflammatory synovitis with progressive pain (especially severe night pain) and increasing stiffness. This is when corticosteroid injection is most effective.

2. Frozen (Stiff) Phase (4-12 months): Capsular fibrosis and contracture with maximal stiffness and global ROM restriction. Pain improves but stiffness is severe.

3. Thawing (Recovery) Phase (12-24 months): Capsular remodeling with gradual improvement in ROM. Pain is minimal. Recovery is slow (2-3° ROM per month).

Total disease duration averages 18-24 months (longer in diabetics: 30 months).

Question 5: Management of Refractory Case

Q: "A 58-year-old patient with frozen shoulder has failed 9 months of conservative management including physiotherapy, NSAIDs, and corticosteroid injection. What are your second-line treatment options?"

A: For refractory frozen shoulder after 6-12 months of failed conservative management, second-line options include:

1. Hydrodilatation (Arthrographic Distension): Image-guided injection of large volume saline + corticosteroid + local anaesthetic to "burst" the contracted capsule. Moderate evidence for benefit; faster ROM improvement than physiotherapy alone.

2. Manipulation Under Anaesthesia (MUA): Controlled forceful stretching under general anaesthetic to break adhesions. Effective for immediate ROM improvement but carries 1-5% fracture risk (humeral neck), particularly in osteoporotic patients. Less commonly used now.

3. Arthroscopic Capsular Release: Keyhole surgery to release the contracted capsule (rotator interval, anterior, +/- posterior release). High success rate (80-90% good/excellent outcomes), lower complication rate than MUA, increasingly preferred option.

Choice depends on patient factors (comorbidities, bone quality), local expertise, and patient preference. Post-intervention intensive physiotherapy is essential to maintain gains.

Viva Scenarios

Scenario 1: Clinical Examination Station

Examiner: "Please examine this patient's shoulder."

Candidate Actions:

• Introduction and consent
• Inspection: Look for asymmetry, muscle wasting, scars
• Palpation: SC joint, clavicle, AC joint, subacromial space, greater tuberosity
• Active ROM: Forward flexion, abduction, external rotation (hand-behind-head), internal rotation (hand-behind-back) – all globally restricted
• Passive ROM: Examiner-led – equally restricted as active (key finding)
• Special Tests: Passive ER with arm at side (most restricted, less than 20°); hand behind back (reaches buttock/sacrum only)
• Power: If ROM allows (often too restricted); if testable, should be normal
• Neurovascular: Brief distal check
• Cervical spine: Quick screen to exclude referred pain

Presentation: "This 52-year-old patient has global restriction of shoulder ROM with a capsular pattern. Both active and passive movements are equally restricted, with external rotation most severely affected at 15°, abduction to 80°, and internal rotation to sacrum. Power is normal, neurovascular exam unremarkable, cervical spine normal. The findings are consistent with frozen shoulder in the frozen phase. I would take a focused history regarding diabetes, thyroid disease, and precipitating events, and obtain plain radiographs to exclude glenohumeral OA or calcific tendinitis."

Scenario 2: Management Discussion

Examiner: "How would you manage this patient?"

Candidate Answer:

"My management would be phase-dependent and tailored to patient factors:

Initial Assessment:

• Confirm diagnosis clinically (capsular pattern, active = passive restriction)
• Plain X-rays to exclude OA, calcific tendinitis, other pathology
• Blood tests: HbA1c (screen diabetes), TFTs (screen thyroid disease), ESR/CRP if atypical

Conservative Management (first-line for all patients):

1. Patient Education: Self-limiting condition, 18-24 months duration, 70-80% functional recovery. Set realistic expectations.
2. Analgesia: Regular paracetamol + NSAIDs (with PPI if indicated). Codeine for severe pain (short-term).
3. Physiotherapy Referral: Gentle ROM exercises, home programme. Avoid aggressive stretching in freezing phase.
4. Intra-articular Corticosteroid Injection: If in freezing (painful) phase. Ultrasound-guided triamcinolone 40mg. Short-term pain relief, may hasten recovery.

Follow-up: Review at 6 weeks and 6 months.

Second-line Options (if failed conservative management after 6-12 months):

• Hydrodilatation (moderate evidence)
• Arthroscopic capsular release (preferred if severe disability)
• MUA (consider fracture risk, less commonly used)

Special Considerations:

• Diabetics: Counsel regarding worse prognosis, monitor glucose with steroid injection, consider earlier intervention
• Bilateral: Significant functional disability; treat dominant arm first; psychological support
• Elderly/Osteoporotic: Avoid MUA (fracture risk); prefer hydrodilatation or arthroscopic release"

Clinical Pearls for Exams

1. Active = Passive: Repeat this mantra. It's the key discriminator.

2. ER > Abd > IR: Know the capsular pattern cold.

3. Diabetes: Always mention diabetes association, 5-fold risk, worse outcomes.

4. Self-Limiting: Reassure it will resolve, but takes 18-24 months.

5. Steroid Injection Timing: Most effective in freezing phase (inflammatory), not frozen/thawing.

6. MUA Fracture Risk: Always mention 1-5% humeral neck fracture risk; avoid in osteoporosis.

7. Investigation: X-ray to exclude other pathology; MRI not routine.

8. Phase Recognition: Identify which phase patient is in – guides treatment (steroid injection in freezing; stretching in thawing).

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances and be made in consultation with appropriate specialists. Always follow local protocols and guidelines.